The Koeln Platform (Partner 3, MEK, Germany) will install an optical imaging camera provided by BIOSPACE (Partner 6, BIOSP, France) in order to make correlations between microPET and optical imaging of gene expression to follow the effects of gene and other molecular targeted therapy. Most important issue is the direct comparison of sensitivity and spatial resolution with regards to non-invasive assessment of gene expression by both imaging methods.
MATHODIC (Partner 40, MATHODIC, Germany) will be involved for software solutions for imaging-coregistration of MRI, PET and optical imaging for cell trafficking.